Glenhill Advisors’s China Pharma Holdings CPHI Stock Holding History

Glenhill Advisors’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-400	Closed	-$44K	–	2
2018 Q2	$44K	Hold	400	–	–	0.22%	6
2018 Q1	$63K	Hold	400	–	–	0.01%	31
2017 Q4	$35K	Hold	400	–	–	﹤0.01%	39
2017 Q3	$35K	Hold	400	–	–	﹤0.01%	42
2017 Q2	$46K	Hold	400	–	–	﹤0.01%	51
2017 Q1	$52K	Hold	400	–	–	﹤0.01%	44
2016 Q4	$52K	Hold	400	–	–	﹤0.01%	44
2016 Q3	$43K	Hold	400	–	–	﹤0.01%	44
2016 Q2	$48K	Hold	400	–	–	﹤0.01%	40
2016 Q1	$34K	Hold	400	–	–	﹤0.01%	47
2015 Q4	$31K	Hold	400	–	–	﹤0.01%	45
2015 Q3	$40K	Hold	400	–	–	﹤0.01%	48
2015 Q2	$72K	Hold	400	–	–	0.01%	49
2015 Q1	$68K	Hold	400	–	–	0.01%	47
2014 Q4	$60K	Hold	400	–	–	﹤0.01%	51
2014 Q3	$50K	Hold	400	–	–	﹤0.01%	51
2014 Q2	$77K	Hold	400	–	–	0.01%	94
2014 Q1	$101K	Hold	400	–	–	0.01%	114
2013 Q4	$69K	Hold	400	–	–	0.01%	115
2013 Q3	$56K	Hold	400	–	–	0.01%	116
2013 Q2	$42K	Buy	+400	New	+$46.7K	﹤0.01%	57

Other funds holding CPHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return

Glenhill Advisors's CPHI Position: Q3 2018 in Review

Glenhill Advisors sold out of China Pharma Holdings (CPHI) in Q3 2018, closing a stake of 400 shares — an estimated $44K sold.

Glenhill Advisors first reported a position in CPHI in Q2 2013 and held it in 21 quarters. The position peaked at $101K in Q1 2014. 8 funds tracked by Wall St. Rank hold CPHI as of Q3 2018.

Glenhill Advisors reported no remaining China Pharma Holdings position as of Q3 2018 after selling out during the quarter.
Glenhill Advisors sold 400 China Pharma Holdings shares in Q3 2018, an estimated $44K.
Glenhill Advisors first reported a position in China Pharma Holdings in Q2 2013 and held it in 21 quarters.
Glenhill Advisors's China Pharma Holdings position peaked at $101K in Q1 2014.
8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2018.

Based on Glenhill Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.